Robert Van Den Berg | Director
GlaxoSmithKline Vaccines

Robert Van Den Berg, Director, GlaxoSmithKline Vaccines

Dr. van den Berg is responsible for the translational science activities for the Rockville R&D center of GSK Vaccines. In this role he leads multidisciplinary teams of clinicians, molecular biologists, immunologists, and data scientists with the objective to tackle key scientific questions for GSK discovery and development programs and vaccine technology platforms. For this, the team collaborates with various partners in the academic world, governmental organizations, and other private companies. Dr. van den Berg has served in this role since 2016. He joined GSK in 2010 as bioinformatician supporting translational research. Before this he worked as a postdoctoral researcher at the Katholieke Universiteit Leuven on data integration of heterogeneous biological data. He received a Ph.D. in Life Sciences from the Universiteit van Amsterdam on Multivariate data analysis of microbial fermentation processes.


April 16 Day 2 - 10 Co-conferences @ 14:40

How are we using new immune repertoire knowledge for better vaccine design?

last published: 11/Apr/19 16:05 GMT

back to speakers

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071